Coherus Oncology (CHRS) Capital Expenditures Growth (3y) (2016 - 2025)
Coherus Oncology (CHRS) Capital Expenditures Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 358.32% |
| Jun 30, 2025 | -719.98% |
| Mar 31, 2025 | 97.24% |
| Jun 30, 2024 | -361.65% |
| Mar 31, 2024 | -990.65% |
| Dec 31, 2023 | -67.07% |
| Jun 30, 2023 | -65.25% |
| Mar 31, 2023 | -55.99% |
| Dec 31, 2022 | -59.63% |
| Sep 30, 2022 | 206.82% |
| Jun 30, 2022 | 69.10% |
| Mar 31, 2022 | 22.45% |
| Dec 31, 2021 | 676.39% |
| Sep 30, 2021 | 71.39% |
| Jun 30, 2021 | 336.21% |
| Mar 31, 2021 | 21.42% |
| Dec 31, 2020 | 30.32% |
| Sep 30, 2020 | 5.24% |
| Jun 30, 2020 | 35.37% |
| Mar 31, 2020 | 1.78% |